Bildkälla: Stockfoto

Alligator Bioscience: Positive Topline Results - Redeye

Redeye increases its base case after the positive topline results from OPTIMIZE-1, the phase II study of mitazalimab in pancreatic cancer.

Redeye increases its base case after the positive topline results from OPTIMIZE-1, the phase II study of mitazalimab in pancreatic cancer.
Börsvärldens nyhetsbrev
ANNONSER